ABSTRACT
Purpose: This study examined the effects of 8-week complex training (CT) with blood flow restriction (BFR) on power output and bar velocity. Methods: Twenty-six healthy male university athletes (age: 19.40 ± 0.88 years) completed three sessions of CT with BFR (CT_BFRT, n = 13) or CT-only (i.e., control) (n = 13) per week (i.e., 24 sessions in total). Before and immediately after intervention, participants completed power measurement as assessed by one-repetition maximum (1RM) squat, squat jump (SJ), countermovement jump (CMJ), and mean power (MP), peak power (PP), mean bar velocity (Bar-MV), and peak bar velocity (Bar-PV) during the half-squat jump. Results: Two-way ANOVA models showed significant main effect of time (p < 0.001) but not group (p > 0.89) or interaction (p > 0.37) between group and time on 1RM of the squat, SJ, or CMJ; however, significant interactions were observed in MP (p = 0.03, Cohen's d = 1.39), PP (p = 0.03, Cohen's d = 1.14), Bar-MV (p = 0.049, Cohen's d = 1.26), and Bar-PV (p = 0.01, Cohen's d = 1.56). The post hoc analyses revealed that MP, PP, Bar-MV, and Bar-PV after CT with BFRT were significantly greater compared to all the other three conditions (i.e., pre-CT_BFRT, pre- and post-CT-only). Conclusion: CT with BFR may induce significantly greater improvements in power output and bar velocity during half-squat jump and induce comparable improvements in 1RM of the squat, SJ, and CMJ of males as compared to CT only, suggesting this novel CT with BFR would be a promising strategy to enhance power performance in healthy male university athletes.
ABSTRACT
(1) Background: Hydrogen (H2) may be a potential therapeutic agent for managing Long COVID symptoms due to its antioxidant and anti-inflammatory properties. However, more scientific literature is needed to describe the effects of H2 administration on treating symptoms. A study aimed to investigate the impact of hydrogen-rich water (HRW) administration on the fatigue and dyspnea of Long-COVID patients for 14 consecutive days. (2) Methods: In this randomized, single-blind, placebo-controlled study, 55 participants were recruited, and 23 of them were excluded. A total of 32 eligible participants were randomized into a hydrogen-rich water (HRW) group (n = 16) and a placebo water (PW) group (n = 16) in which they were instructed to consume hydrogen-rich water or placebo water for 14 days, respectively. The participants completed the Fatigue Severity Scale (FSS), Six-Minute Walk Test (6MWT), 30 s Chair Stand Test (30s-CST), Modified Medical Research Council Dyspnea Rating Scale (mMRC), Pittsburgh Sleep Quality Index (PSQI), and depression anxiety stress scale (DASS-21) before and after the intervention. A linear mixed-effects model was used to analyze the effects of HRW. Cohen's d values were used to assess the effect size when significance was observed. The mean change with 95% confidence intervals (95% CI) was also reported. (3) Results: The effects of HRW on lowering FSS scores (p = 0.046, [95% CI = -20.607, -0.198, d = 0.696] and improving total distance in the 6WMT (p < 0.001, [95% CI = 41.972, 61.891], d = 1.010), total time for the 30s-CST (p = 0.002, [95% CI = 1.570, 6.314], d = 1.190), and PSQI scores (p = 0.012, [95% CI = -5.169, 0.742], d = 1.274) compared to PW were of a significantly moderate effect size, while there was no significant difference in mMRC score (p = 0.556) or DASS-21 score (p > 0.143). (4) Conclusions: This study demonstrates that HRW might be an effective strategy for alleviating fatigue and improving cardiorespiratory endurance, musculoskeletal function, and sleep quality. Still, it does not ameliorate dyspnea among Long-COVID patients.